Palvella Therapeutics, Inc.
Pharmaceutical company · Wayne, Pennsylvania, United States · Nasdaq: PVLA
Palvella Therapeutics, Inc. is a pharmaceutical company headquartered in Wayne, Pennsylvania, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker PVLA. It has reported private securities offerings to the US SEC, most recently $9.7 million sold in a notice filed in 2022.
What does Palvella Therapeutics do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $9.7 million sold (2022).
Frequently asked questions about Palvella Therapeutics
Where is Palvella Therapeutics headquartered?
Palvella Therapeutics, Inc. is headquartered in Wayne, Pennsylvania, United States.
What does Palvella Therapeutics do?
Palvella Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Palvella Therapeutics a public company?
Yes. Palvella Therapeutics, Inc. trades on Nasdaq under the ticker PVLA.
When was Palvella Therapeutics founded?
The earliest incorporation on record for Palvella Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Aclaris Therapeutics, Inc.Wayne, Pennsylvania, United States
- Avalo Therapeutics, Inc.Wayne, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.